BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36691015)

  • 21. Clinico-pathological characteristics and prognostic factors of gastrointestinal stromal tumors among a Chinese population.
    Li J; Zhang H; Chen Z; Su K
    Int J Clin Exp Pathol; 2015; 8(12):15969-76. PubMed ID: 26884871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic role of tumor necrosis in patients undergoing curative resection for gastric gastrointestinal stromal tumor: a multicenter analysis of 740 cases in China.
    Liu X; Qiu H; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    Cancer Med; 2017 Dec; 6(12):2796-2803. PubMed ID: 29058376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal stromal tumors of the stomach: A 10-year experience of a single-center.
    Uzunoglu H; Tosun Y; Akinci O; Baris B
    Niger J Clin Pract; 2021 Dec; 24(12):1785-1792. PubMed ID: 34889786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of surgical intervention for imatinib-resistant gastrointestinal stromal tumors in the era of multiple tyrosine kinase inhibitors.
    Wada N; Takahashi T; Kurokawa Y; Nakajima K; Nishida T; Koh M; Akamaru Y; Motoori M; Kimura Y; Tanaka K; Miyazaki Y; Makino T; Yamasaki M; Eguchi H; Doki Y
    Surg Today; 2021 Sep; 51(9):1506-1512. PubMed ID: 33570662
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib therapy after resection of high-risk gastrointestinal stromal tumors in Chinese patients: a median follow-up of 48 months.
    Lei C; Zhao B; Wang Q; Ge L; Wang H
    J BUON; 2018; 23(2):460-467. PubMed ID: 29745093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gastrointestinal stromal tumors (GIST) related emergencies.
    Sorour MA; Kassem MI; Ghazal Ael-H; El-Riwini MT; Abu Nasr A
    Int J Surg; 2014; 12(4):269-80. PubMed ID: 24530605
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic Value of Bleeding in Gastrointestinal Stromal Tumors: A Meta-Analysis.
    Fan X; Han H; Sun Z; Zhang L; Chen G; Mzee SAS; Yang H; Chen J
    Technol Cancer Res Treat; 2021; 20():15330338211034259. PubMed ID: 34323156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China.
    Chen Q; Li C; Yang H; Zhao H; Zhao J; Bi X; Li Z; Huang Z; Zhang Y; Zhou J; Cai J
    Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):317-323. PubMed ID: 30447909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood neutrophil-to-lymphocyte ratio is associated with prognosis in advanced gastrointestinal stromal tumors treated with imatinib.
    Rutkowski P; Teterycz P; Klimczak A; Bylina E; Szamotulska K; Lugowska I
    Tumori; 2018 Dec; 104(6):415-422. PubMed ID: 29714669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment and prognosis of 108 patients with high-risk gastrointestinal stromal tumor].
    Lei C; Liu L; Wang Q; Wang H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1300-1304. PubMed ID: 27928804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term survival outcome with tyrosine kinase inhibitors and surgical intervention in patients with metastatic or recurrent gastrointestinal stromal tumors: A 14-year, single-center experience.
    Kim JH; Ryu MH; Yoo C; Chae H; Na H; Beck M; Kim BS; Yoo MW; Yook JH; Kim BS; Kim KH; Kim CW; Kang YK
    Cancer Med; 2019 Mar; 8(3):1034-1043. PubMed ID: 30693663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric and Small Intestine Gist: Results of 156 Cases in 20 Years.
    Lopez Gordo S; Bettonica C; Miró M; Estremiana F; Aranda H; Farran L
    J Gastrointest Cancer; 2022 Jun; 53(2):451-459. PubMed ID: 33871798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of biological characteristics and prognosis on gastrointestinal stromal tumor with PDGFRA gene mutation].
    Qi C; Pan F; Li J; Li Y; Gao J; Shen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1280-1284. PubMed ID: 30506540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib.
    Gronchi A; Bonvalot S; Poveda Velasco A; Kotasek D; Rutkowski P; Hohenberger P; Fumagalli E; Judson IR; Italiano A; Gelderblom HJ; van Coevorden F; Penel N; Kopp HG; Duffaud F; Goldstein D; Broto JM; Wardelmann E; Marréaud S; Smithers M; Le Cesne A; Zaffaroni F; Litière S; Blay JY; Casali PG
    JAMA Surg; 2020 Jun; 155(6):e200397. PubMed ID: 32236507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GASTROINTESTINAL STROMAL TUMOR: OUTCOMES OF THE PAST DECADE IN A REFERENCE INSTITUTION IN SOUTHERN BRAZIL.
    Everling EM; Marchet D; DE-Antoni NM; Isbert BBM; Alves GV; Grezzana-Filho TJM
    Arq Bras Cir Dig; 2022; 35():e1658. PubMed ID: 35730887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes.
    Yang F; Jin C; Du Z; Subedi S; Jiang Y; Li J; Di Y; Zhou Z; Tang F; Fu D
    Am J Surg; 2013 Sep; 206(3):360-7. PubMed ID: 23673012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Pathological Prognostic Score (PPS) to Identify "Very High-Risk" Patients: a Multicenter Retrospective Analysis of 506 Patients with High Risk Gastrointestinal Stromal Tumor (GIST).
    Liu X; Qiu H; Wu Z; Zhang P; Feng X; Chen T; Li Y; Tao K; Li G; Sun X; Zhou Z;
    J Gastrointest Surg; 2018 Dec; 22(12):2150-2157. PubMed ID: 30030719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgically managed gastrointestinal stromal tumors: a comparative and prognostic analysis.
    Hassan I; You YN; Shyyan R; Dozois EJ; Smyrk TC; Okuno SH; Schleck CD; Hodge DO; Donohue JH
    Ann Surg Oncol; 2008 Jan; 15(1):52-9. PubMed ID: 18000711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.
    Belev B; Brčić I; Prejac J; Golubić ZA; Vrbanec D; Božikov J; Alerić I; Boban M; Razumović JJ
    World J Gastroenterol; 2013 Jan; 19(4):523-7. PubMed ID: 23382631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
    Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.